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Abstract 
Melt electrospinning in a direct writing mode is a recent additive manufacturing approach to 
fabricate porous scaffolds for tissue engineering applications. In this study we describe porous 
andcell-invasive poly (ε-caprolactone) scaffolds fabricated by combining melt electrospinning and a 
programmable x-y stage. Fibers were 7.5 ± 1.6 m in diameter and separated by interfiber distances 
ranging from 8 m to 133 μm, with an average of 46 ± 22 m. Micro-computed tomography revealed 
the resulting scaffolds had a highly porous (87%), three-dimensional structure. Due to the high 
porosity and interconnectivity of the scaffolds, a top-seeding method was adequate to achieve 
fibroblast penetration, with cells present throughout and underneath the scaffold. This was confirmed 
histologically, whereby a 3D fibroblast-scaffold construct with full cellular penetration was produced 
after 14 days in vitro. Immunohistochemistry was used to confirm the presence and even distribution 
of the key dermal extracellular matrix proteins, collagen type I and fibronectin. These results show 
that melt electrospinning in a direct writing mode can produce cell invasive scaffolds, using simple 
top-seeding approaches. 
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1. Introduction  
 Interest in scaffolds for tissue engineering (TE) applications fabricated using additive 
manufacturing (AM) principles is continually increasing as crucial parameters can be systematically 
controlled. Scaffold thickness, filament diameter, pore size and interconnectivity required for cell 
invasiveness can all be altered in a broad range of morphologies [1-5]. One melt extrusion based AM 
approach, namely fuse deposition modeling (FDM), permits the accurate control of scaffolds 
properties; however, the lower limit of filament diameter is restricted to approximately 100 m due to 
the viscosity of the polymer melt being extruded through a small diameter orifice [1, 6]. Significantly 
lower filament resolutions can be achieved in a separate AM process using colloidal ink systems 
deposited in a direct writing mode [1, 2, 7, 8]. This approach uses colloidal systems to produce 
orderly substrates with fiber diameters between approximately 0.5 m and 10 m [1]. However, 
biomaterials need to be formulated into polyelectrolyte inks and significant manufacturing times are 
needed to manufacture the scaffolds [6]. 
 The orderly structures of such AM produced scaffolds contrast with the non-woven 
nanofibrous meshes produced by electrostatic drawing (electrospinning) [9]. Electrospun meshes 
demonstrate excellent in vitro compatibility, however, most meshes perform as substrates [10-13], 
rather than scaffolds that permit cell infiltration, as they have pores sizes too small to allow cell 
invasion [6, 14-16]. While there are reports of penetration into electrospun meshes, these are typically 
restricted to depths of less than 150 m and complex and taxing strategies are needed to create open 
pores [17-19]. 
This importance of cell invasiveness has been recognized by many electrospinning 
researchers and has prompted investigation of approaches to produce cell-invasive scaffolds [20]. 
These include electrospinning onto ice crystals as they grow off a collector [21, 22], salt leaching 
[23], retrieving fibers collected onto water (hydrospinning) [24], and electrospinning onto patterned 
[25-27] and complex collectors through the use of needle-like probes attached to a flat collecting 
surface [28]. In addition, bimodal scaffolds have been recently described in which solution 
electrospinning is combined with larger scale fabrication techniques to increase the pore size [20, 29-
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33]. This emerging trend of bimodal scaffolds provides a straightforward approach to produce cell 
invasive scaffolds while utilizing the benefits of sub-micron filaments.  In another study, solution 
electrospinning was combined with melt electrospinning, to create a bimodal scaffold where the larger 
melt electrospun fibers combined with smaller solution electrospun fibers resulted in a 3D cell-
invasive scaffold [30]. Melt electrospun meshes typically have diameters between 2 and 20 m [9, 34, 
35]. 
In addition to slightly larger fibers, the non-conductive and viscous electrified jet produced 
during melt electrospinning can be accurately deposited [36] making it suitable as a direct-writing 
technique to produce scaffolds with accurately placed fibers stacked on top of each other [37, 38]. 
This process allows for scaffold pore size to be tailored, paving the way for better control over cell 
invasiveness. Melt electrospinning in a direct writing mode is therefore a new AM approach to 
produce orderly scaffolds for TE applications.  
One area that can benefit from this new fabrication technique is the development of dermal 
substitutes. Early examples of dermal substitutes for formation of an in vitro skin equivalent have 
been reported using collagen gels [39-41]. Bell et al. [40, 41] were able to demonstrate a collagen 
based dermal substitutes supported keratinocyte differentiation, however, a fundamental limitation 
associated with the use of collagen is contraction of the gels [42]. This limitation has not gone 
unnoticed, with many studies carried out in an attempt to find alternative constructs [43-46]. One 
study conducted by Ng et al. [47] compared two commercially available collagen based matrices with 
two non-collagen based scaffolds, fabricated from both natural and synthetic polymers. While it was 
shown that three out of the four scaffold types were capable of supporting the formation of dermal-
like tissue, it was noted that for the non-collagen based scaffold that supported tissue formation, the 
dermal fibroblasts were unable to completely infiltrate the scaffold structure, highlighting the 
importance of scaffolds that allow cell infiltration. 
This paper details melt electrospinning in a direct writing mode to produce scaffolds, which 
are cell invasive in vitro. We investigated the scaffold morphology with scanning electron microscopy 
(SEM) and micro-computed tomography (-CT), showing that the scaffolds’ pores are both 
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interconnected and cell invasive, with excellent fibroblast infiltration after a simple top-seeding 
method and culturing under static conditions. Furthermore, we demonstrate that important dermal 
extracellular matrix (ECM) proteins are produced within the cell-scaffold construct via 
immunohistochemical methods.  
 
2. Experimental Methods 
2.1. Scaffold Fabrication 
Melt electrospun scaffolds were fabricated based on a direct writing approach previously 
described, where a translating x-y stage is used to collect the fibers [37]. Briefly, poly(-caprolactone) 
(PCL) (Perstorp, Mn ~ 83 kDa), pellets were placed into a 2 mL luer lock syringe (B-Braun, Australia) 
and heated to 80 °C in an oven overnight to remove any air bubbles from the melt. A blunt 23 G 
needle acting as the spinneret was attached to the syringe and placed into a water circulating system 
heated to 78 °C. The PCL melt was then electrospun using a collector distance of 30 mm, a flow rate 
of 10 L/h and a voltage of 10 kV applied to the spinneret. Writing with the PCL fibers was achieved 
by collecting on a grounded plate connected to a programmable x-y stage, controlled using Mach 3 
software. A schematic of the electrospinning writing apparatus is shown in figure 1(a). The 
programmed design (figure 1(b)) consisted of interlaced diagonal lines at a translational velocity of 
2.5 × 10
-2
 m/s, which was looped four times for each scaffold. Scaffolds with randomly deposited 
fibers were prepared on an alternative in-house built apparatus with a static collection stage [48], 
under comparable conditions. 
 
2.2. Scaffold Characterization 
Scaffolds were visualized using light microscopy (Zeiss, Axio Scope) prior to seeding cells. 
Images were recorded using Axio Vision software (version 4.8.2) at three positions along the z-axis 
and were then analyzed using Image J (Version 1.45c, NIH) to determine both fiber diameter and 
interfiber distance (10 measurements per image). From this, each scaffold was directly assessed in 
terms of fiber diameter and distance between fibers prior to in vitro experiments. An overall 
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assessment of the scaffold was achieved using -CT (Xradia MicroXCT-400) where a representative 
sample was scanned at a resolution of 0.786 μm, 80 kV, and an integration time of 50 s. Scaffold 
porosity was obtained by applying a bone morphometric analysis algorithm that determines the ratio 
of volume occupied by the scaffold fibers to the total volume scanned [49]. Optical images of the 
scaffold were taken on a Canon power shot A620 digital camera attached to a stereomicroscope 
(Stemi 2000C, Zeiss) fitted with a  digital camera adapter (426126, Zeiss). 
 
2.3. Dermal Fibroblast Isolation 
Primary human dermal fibroblasts were isolated from surgical discards of consenting patients 
undergoing elective surgery. Ethics approval was obtained from the Queensland University of 
Technology’s Review Board (3673H) and associated hospitals, along with written informed consent 
from patients prior to undergoing surgery. In addition, the studies were conducted in strict accordance 
with the Declaration of Helsinki Principles. 
Dermal skin sections were comminuted and digested in a 0.05% collagenase solution (Gibco) 
overnight at 37 °C. Following digestion, the suspension was centrifuged at 400 g for 10 min before 
removing the supernatant and re-suspending the resulting cell pellet prior to transfer into a tissue 
flask. Fibroblasts were incubated in Dulbecco’s Modified Eagle’s Medium (DMEM, Invitrogen, high 
glucose) supplemented with fetal calf serum (10%, FCS, Hyclone), penicillin, streptomycin and L-
glutamine (all Invitrogen). Fibroblasts were maintained in a humidified atmosphere (5% CO2) at 37 
°C with the medium refreshed every 3 – 5 days. All cells used were at P5. 
 
2.4. Cell Seeding onto Scaffolds 
Prior to cell seeding, 8 mm diameter circular scaffolds were prepared from the square 
scaffolds using a biopsy punch (Stiefel). Each scaffold was sterilized under UV irradiation for 20 min 
on each side and placed in a graded ethanol series (100%, 90%, 70%) to pre-wet the scaffolds [50], 
followed by washing three times in phosphate buffered saline (PBS) before overnight incubation in 
medium (DMEM). Human dermal fibroblasts were seeded using a top seeding static method onto 
each scaffold (2 × 10
4
 cells / scaffold). Fibroblasts were seeded and maintained in DEME (10% FCS) 
 7 
 
supplemented with 50 g/mL ascorbic acid (Sigma Aldrich) for either 7 or 14 days, with media 
replaced every alternate day. On completion, the scaffolds were fixed as described below and 
prepared for analysis; all scaffolds were visualized with immunofluorescence and SEM, while 
fibroblast infiltration was additionally assessed with histology. 
 
2.5. Immunofluorescence  
Cell-scaffold constructs were removed from the media, washed three times in PBS 
(containing Mg
2+
 and Ca
2+
) and fixed in 4% paraformaldehyde at 4 °C for 12 h. Constructs were 
removed from the fixative and the cells permeabilized in 0.2% Tween 20 for 75 min at room 
temperature (RT), and incubated in 1% bovine serum albumin for 1 h at 37 °C to block nonspecific 
binding. Between each step, the scaffolds were washed three times with PBS. Scaffolds were then 
probed for nuclei (propidium iodide, Sigma, 1 g/mL) and f-actin, (Alexa Fluor 488 phalloidin, 
Invitrogen, 200U/mL) by incubation in phalloidin for 20 min at RT, washed three times in PBS, 
followed by incubation in propidium iodide for a further 20 min at RT. Fluorescence images were 
captured using a Leica TCS SP5 confocal laser scanning microscope (Leica Microsystems, Wetzlar, 
Germany) at Ex 495 and Em 535 for visualization of f-actin, Ex518 and Em 617 for nuclei, and 458 
in reflectance mode for visualization of the scaffold fibers. Images were collected along the z-axis of 
the scaffold at 1.5 μm intervals then merged together to give a projected 3D representation. 
 
2.6. Scanning Electron Microscopy 
Cell-scaffold constructs were fixed in 3% glutaraldehyde in 0.1 M cacodylate buffer at 4 °C 
for a minimum of 12 h prior to SEM analysis. After fixation the constructs were placed into 0.1 M 
cacodylate buffer (2 × 10 min), osmium tetroxide (1 h) and ddH2O (2 × 10 min) before dehydration in 
graded ethanol series (50% 2  10 min, 70% 2 × 10 min, 90% 2 × 10 min, 100% 2 × 15 min) and final 
immersion in hexamethyldisilazane (2 × 30 min). Constructs were allowed to dry for 2 h, then 
mounted onto stubs, and left overnight to ensure complete removal of solvent. Constructs and blank 
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scaffolds were gold sputter-coated for SEM visualization (FEI Quanta 200 Environmental SEM) 
using an accelerating voltage of 10 kV.  
 
2.7. Histology and Immunohistochemistry 
Cell-scaffold constructs were fixed in 4% PFA at 4 °C for a minimum of 12 h. To facilitate 
infiltration of the OCT embedding media (Tissue-Tek) and reduce possible ice crystal formation, the 
constructs were placed in a series of solutions (20% sucrose, 40% sucrose, 40% sucrose/20% OCT, 
20% sucrose/60% OCT; in PBS, 2 h each) before finally being placed in 100% OCT (2 h) and frozen 
in liquid nitrogen. Samples were sectioned using a cryostat (Leica) at -20 °C, with 5 m sections 
collected on Superfrost Plus
®
 (HD Scientific) microscope slides. Following sectioning, the cell-
scaffold constructs were stained using hematoxylin and eosin (both HDS Scientific). Briefly, sections 
were washed in PBS followed by staining with Harris’ hematoxylin for 10 min, and eosin for 5 min. 
Samples were then dehydrated, and mounted with cover slips using PERTEX mounting medium. 
Sections of the cell-scaffold constructs were stained for the production of dermal ECM proteins 
collagen type I and fibronectin. Following cryosectioning, sections were washed in PBS, and non-
specific binding was blocked using 1% BSA in PBS/0.1% Tween 20. Primary antibodies were diluted 
in 1% BSA/PBST and incubated on the sections for 2 h at RT. Primary antibodies used were 
monoclonal mouse anti-human collagen type I (MP Biomedicals, 1:1000) and monoclonal mouse 
anti-human fibronectin (BD Biosciences, 1:500). Antibody detection was performed using the Mach4 
Universal HRP polymer detection kit (Biocare Medical). Following incubation with the primary 
antibodies, sections were incubated with horseradish peroxidase (HRP)-conjugated anti-mouse 
secondary antibodies for 15 min at RT (Biocare Medical). HRP was detected using 3,3’-
diaminobenzidine tetrahydrochloride (DAB, Biocare Medical) through formation of brown 
pigmentation. Sections were then counterstained with hematoxylin, dehydrated, and mounted with 
coverslips using PERTEX. 
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3. Results and Discussion 
 
3.1. Scaffold Characterization 
Melt electrospun scaffolds were prepared using two different methods. One was to prepared 
scaffolds containing randomly deposited fibers with the use of a static collector, while the other 
method used a collector attached to a movable x-y stage for melt electrospinning in a direct writing 
mode. An illustration of the x-y stage and melt electrospinning apparatus are shown in figure 1, as 
well as with the interlaced diagonal line program for movement of the stage.  The simple method of 
moving the collector results in scaffolds with straight fibers and periodic placement when compared 
with scaffolds prepared onto a static collector as indicated by the SEM images in figure 2(a) and 2(b), 
respectively. Video footage capturing scaffold fabrication in a direct writing mode is shown in the 
supplementary data [S1]. Based on the parameters utilized for fabrication of the reported scaffolds, 
manufacture time per scaffold was approximately 120 mins, though alteration to scaffold parameters, 
particularly diameter and pore size can decrease the time of fabrication. The straight fiber morphology 
is dependent on the translational speed of the collector, whereby straight fibers can be obtained if the 
collector is translated at a faster speed than the depositing viscous jet [37]. In this case, the 
translational speed of 2.5 × 10
-2
 m/s resulted in the fiber morphology seen in figure 2(a). Irrespective 
of the mode of collection, the fibers were smooth and defect-free and exhibited good interconnectivity 
between pores. Evidence of fiber fusion in the direct written scaffolds is shown in figure 2(a) insert. 
While fusion did not occur at all fiber junctions, similar results have previously been shown at a 
comparable collection distance [35], as degree of fiber fusion is due to the rate at which the molten 
polymer jet cools prior to collection.  
Fiber diameter and pore size, (interfiber distance), were determined from SEM and optical 
microscope imaging, followed by analysis using Image J software. For both static and written 
scaffolds the fiber diameters were similar, namely, 6.8 ± 0.6 m (average ± SD) for the static method 
and 7.5 ± 1.6 m for the written approach (p = 0.05). In contrast, the pores were 16 ± 6 m in size for 
the scaffolds prepared on the static collector compared with 46 ± 22 m for the written scaffolds (p = 
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0.00). The distribution of fiber diameters and pore sizes for the electrospun scaffolds are shown in 
figure 3. When electrospinning onto a static collector, increasing the fiber diameter leads to a 
corresponding increase in pore size due to the interdependent relationship between these two 
parameters [51]. By accurately placing the fibers, with the aid of direct writing, the porosity of the 
electrospun mesh was further increased without increasing the fiber diameter.  
 In addition to SEM analysis, optical imaging of a representative scaffold (figure 4a) shows 
the long-range order obtainable using direct writing. The scaffolds could be readily handled without 
folding or breaking, although pressure from forceps can deform the scaffold (top of scaffold, figure 
4(a)). Furthermore, the scaffolds could be analyzed via CT methods and Figure 4(b) shows a -CT 
micrograph of a representative scaffold. Orderly stacking of the fibers was shown, with a morphology 
not dissimilar to -CT imaging of FDM scaffolds [52], except that the fiber dimensions reported here 
are an order of magnitude smaller (7.5 ± 1.6 µm compared to c.a. 100 µm for FDM). With continual 
improvements in imaging technology, CT resolutions of less than 1 μm are now obtainable, making 
CT a viable characterization technique for scaffolds fabricated by electrospinning with low micron 
diameter fibers. In addition to 3D visualization, -CT enabled the calculation of scaffold porosity at 
87%, which is similar compared to electrospun scaffolds previously reported [19]. Traditionally the 
porosity of electrospun scaffolds has been determined through mercury porosimetry or gravimetrical 
methods [53], however these have limitations as calculations are based on applied assumptions [54] 
while the pressure applied during porosimetry measurements can cause samples to collapse[52]. A 
movie capturing 3D visualization of the direct written scaffolds through µ-CT analysis is shown in the 
supplementary data [S2]. 
 
3.2. Evaluation of Dermal Fibroblast Infiltration 
Seeding of dermal fibroblasts onto the PCL scaffolds was accomplished using a simple static 
top seeding method to examine the interactions and infiltration of the cells into the scaffolds. After 7 
and 14 days in vitro the constructs were characterized with confocal microscopy, SEM and histology. 
Fibroblasts grown on 2D glass cover slips (figure 5(a)) and the electrospun written scaffold after 7 
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days in vitro (figure 5(b)) displayed typical elongated morphology; this was more pronounced when 
the fibroblasts were grown on the electrospun written scaffold. After 7 days in vitro, fibroblasts 
spanned across both the pores and fibers of the scaffold, as indicated in figure 5(b) by the yellow and 
white arrowheads, respectively. Previous studies using FDM scaffolds have shown that initial cellular 
attachment occurs at points of intersecting fibers [3, 55, 56], from where the attached cells migrate 
outwards. This is also reflected in this study (figure 5(b)), where an increase in fibroblast density is 
seen in regions with a greater proportion of intersecting fibers (red circle), compared to regions with a 
lower proportion of intersecting fibers (blue circle). After 14 days in vitro, the scaffold surface was 
completely covered by fibroblasts (figure 5(c)). Fibroblasts also bridged between adjacent scaffold 
struts, with inter-fiber distances ranging from 8 to 133 μm. Studies carried out by Sun et al. [57] have 
previously shown dermal fibroblasts are able to bridge distances up to 200 m following 14 days in 
vitro. Fibroblast attachment to the scaffold shown in figure 5(b) highlights the scaffold dimensions 
achieved, concerning fiber diameter and pore size, are on a scale that is in relation to the size of the 
fibroblasts. The obtained fiber diameters and pore sizes have allowed the fibroblasts seeded on the 
scaffolds to ‘view’ and interact with them as a true 3D construct rather than a flat substrate.  
The top, underside and cross-sections of the cell-scaffold constructs were evaluated for 
fibroblast infiltration using SEM. After 7 days in vitro, dermal fibroblasts had covered substantial 
areas of both the top and underside of the scaffold (figure 6(a)-(b)), while the cross-section (figure 
6(c)) shows ECM deposited through the entire thickness of the scaffold. Figure 6(d), clearly shows 
cellular anchorage to the fibers, indicated by the arrows, and fibroblasts spanning across scaffold 
pores both laterally and through the scaffold thickness (z-axis). Figures 6(c) and 7(c) compare cross-
sections of the constructs following 7 and 14 days in vitro, respectively, where an increase in the 
amount of ECM deposited between the two time points was evident.  This confirms the infiltration of 
dermal fibroblasts throughout the entire thickness of the scaffold, and suggests cellular proliferation 
with increased incubation period. Figure 7(a), shows an SEM image of a continuous cell layer on the 
upper surface of the construct after 14 days, supporting immunofluorescence results (figure 5(c)).  
The scaffolds reported within this study were fabricated by melt electrospinning, though, the 
attraction of solution electrospun scaffolds for TE applications stems from the ability to produce 
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nanofibers that hypothetically  mimic the structural component of ECM [58]. However, nanofibers 
may not be as advantageous as microfibers for cell attachment, as previous studies have shown 
enhanced cellular proliferation on micron sized fibers compared to nanofibers [29, 59-62]. 
Interestingly, Chen et al. [61] found that for nanofibers, as fiber diameter increased, cellular adhesion 
and proliferation decreased but remained constant when fiber diameter was altered within the micron 
range. Furthermore, micron-scaled structures are an important element in bimodal scaffolds, where 
nanofibrous elements are combined with larger ones [30]. 
Fibroblast infiltration, in addition to SEM analysis, was assessed via histological methods on 
the cell-scaffold constructs after 14 days in vitro. A cross-section of the constructs stained with 
hematoxylin and eosin (H&E) shown in figure 8(a) revealed the presence and infiltration of cells 
throughout the scaffold. The expansion in figure 8(b) shows presence of fibroblast nuclei through the 
entire thickness of the scaffold, indicated by the black arrows. Round polymer fiber cross-sections 
(indicated by the yellow arrows) were evident throughout the scaffold and were coated with increased 
amount of cellular components due to the cells using the struts as their initial attachment points. In the 
continual pursuit to create scaffolds for TE applications, a key issue for consideration is the ability to 
obtain homogenous cellular colonization required to ultimately cultivate reconstructed tissue [27], a 
result which has been shown in the presented data. 
A future goal for these PCL scaffolds is their use as a dermal component in the development 
of an in vitro skin model. In the quest to tissue engineer a dermal substitute, in addition to cellular 
infiltration of the scaffold material, production and deposition of ECM is a crucial requirement. While 
dermal ECM is comprised of many constituents, the main structural ECM molecule is collagen, with 
type I the most abundant within the dermis and as well as fibronectin, a key dermal ECM molecule. 
Immunohistochemical staining of the cell-scaffold constructs after 14 days in vitro for collagen type I 
and fibronectin shown in figures 8(c) and 8(d) respectively, confirm the presence of both these dermal 
ECM proteins. Both were distributed throughout the thickness of the scaffold, with the greatest 
density seen of collagen seen underneath the cells in the upper part of the construct. Negative controls 
for both collagen and fibronectin, replacing primary antibody incubation with the blocking solution 
did not show presence of the brown DAB precipitate (data not presented).  
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For an in vitro model to successfully mimic the functions of native skin, the formation of a 
basement membrane is crucial [63-65]. In vitro skin models currently detailed within the literature 
commonly use collagen gels [66, 67] or alternatively de-epidermised dermis as the dermal component 
[68], which retains the native basement membrane. When collagen gels have been used, the gels are 
seeded and conditioned with fibroblasts, onto which keratinocytes are seeded. This approach has been 
shown to achieve adequate separation between the dermal and epidermal layers, resulting in creation 
of the basement membrane in vitro. Formation of the fibroblast sheet on the seeded surface of the 
scaffold in the present study, in conjunction with the presence of collagen type I and fibronectin, 
displays the initial step of dermal layer formation, and a surface for subsequent seeding of 
keratinocytes. It is noteworthy that no evidence of scaffold contraction was observed after seeding the 
melt electrospun materials with fibroblasts, which may give them an advantage over substrates for 
which contraction can be a problem. 
The ability to combine melt electrospinning and direct writing allows the fabrication of 
scaffolds with control over fiber diameter through manipulation of electrospinning variables [37], as 
well as control over fiber placement and therefore scaffold design. These factors increase the number 
of potential TE applications for scaffolds fabricated using this combination. The ability to produce 
aligned fibers as a way of directing cell growth has shown to be successful in the engineering of blood 
vessels [69] as well as in peripheral nerve regeneration [70]. Additionally, such an approach can be 
used in the design and fabrication of tubular scaffolds, whereby design parameters such as fiber 
diameter, the number of fibers and the fiber winding angle can be used to control scaffold features 
such as pore size and porosity [38]. 
Fibroblast attachment and infiltration throughout the thickness of the scaffolds indicates that 
direct written scaffolds are true 3D structures. TE scaffolds are often prepared by techniques such as 
particle leaching, thermal induced phase separation, electrospinning or various solid freeform (SFF) 
fabrication techniques [6_ENREF_6], with the fabrication method dependent on the desired end 
application. At one end of the spectrum, are nano-scale scaffolds, solution electrospun mats, could be 
regarded as a textured 2D substrate. As the resulting pore sizes of these scaffolds restrict cell 
infiltration, cell migration occurs across the surface rather than by infiltration into the scaffold. At the 
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other end of the spectrum are micron-scale SFF scaffolds, for which it could be similarly suggested 
that cells ‘see’ these scaffolds as curved 2D surfaces since these scaffold struts are, in general, an 
order of magnitude in size larger than the cells themselves. The results reported here show that 
fabrication of a scaffold that fills the void between the current nano- and micron- scale scaffolds 
allows fibroblasts to attach to and infiltrate though the electrospun written scaffolds, both in a lateral 
and vertical direction, producing a true 3D fibroblast-scaffold construct. This result is due to the fiber 
diameter and interfiber distance arrangement that can be produced through combining melt 
electrospinning with direct writing. 
 
 
4. Conclusion 
The current study uses melt electrospinning in combination with direct writing for the 
preparation of PCL scaffolds with micrometer sized fibers (7.5 ± 1.5 m diameter) and interfiber 
distances suitable to allow cellular infiltration (46 ± 22 m). Melt electrospun PCL fibers were 
collected a programmable x-y stage, resulted in the fibers being linearly placed, confirmed by both 
electron microscopy and micro-computed tomography. The electrospun written scaffolds were 
subsequently seeded and incubated with dermal fibroblasts, and cellular infiltration as well as ECM 
production was assessed through immunofluorescent, electron microscopy, histological and 
immunohistochemical evaluation. These results showed fibroblast infiltration throughout the scaffold, 
with H&E staining of the cell-scaffold constructs confirming fibroblast nuclei present, along with the 
production of key dermal ECM proteins, collagen type I and fibronectin, though the entire thickness 
of the scaffold.  
While the PCL scaffolds shown here are currently being investigated for TE of skin, 
demonstration of a true 3D cell-scaffold construct developed through the electrospinning writing of 
polymers, and more importantly control over scaffold design, paves the way for precision-made 
scaffolds. The real utility of melt electrospinning in a direct writing mode is that it produces porous 
scaffolds on a scale that fills the current research gap between solution electrospinning and many of 
the conventional AM techniques. 
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Figure 1: A) A schematic of the apparatus used to produce the melt electrospun scaffolds in a direct 
writing mode. B) The pattern used to program the x-y stage and produce the electrospun written 
scaffolds. The pattern length and height was 15 mm, and the red ring indicates approximately where 
scaffolds were cut with a biopsy punch. (Note: pattern is not drawn to scale) 
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Figure 2: Scanning electron microscopy of PCL scaffolds comparing fiber morphology and 
orientation for melt electrospun scaffolds via A) direct writing, evidence of fused fibers indicated by 
the arrows in the insert (scale bar = 50 m) and B) static conditions.  
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Figure 3: Frequency histograms for electrospun written scaffolds showing A) fiber diameters ranging 
from 4.1 µm to 12.8 µm with an average diameter ± SD of 7.5 ± 1.6 µm, and B) the inter-fiber 
distance ranging from 8 µm to 133 µm, with an average of 46 ± 22 µm. (n=30). 
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Figure 4: Visualization of a melt electrospun scaffold produced in a direct writing mode through A) 
optical and B) µ-CT methods.   
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Figure 5: Scanning laser confocal microscopy of fibroblasts on A) a glass cover slip, and the 
electrospun written scaffolds following B) 7 and C) 14 days. The white arrows in B show fibroblast 
migration along the fibers and the yellow arrows show spreading across scaffold voids. Regions 
within the scaffold of high and low fiber intersections/density and corresponding high and low 
fibroblast density are shown by the red and blue circles, respectively. Cell-scaffold constructs were 
stained with phalloidin (green) and propidium iodide (red), for visualization of actin filaments and 
nuclei, respectively. 
  
 23 
 
 
Figure 6: Fibroblast infiltration of the electrospun written scaffold after 7 days was assessed via SEM. 
Micrographs show fibroblasts present on the A) top side, B) underside, and C) within the thickness of 
the scaffold, with D) a magnified image of C. The arrows in D indicate points of fibroblast attachment 
and anchorage to the PCL fibers. The image shown in D represents the highlighted scaffold segment 
in C. 
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Figure 7: Fibroblast infiltration of the electrospun written scaffold after 14 days was assessed via 
SEM. Micrographs show fibroblasts present on the A) top side, B) underside, and C) within the 
thickness of the scaffold. The arrows in C indicate points of fibroblast attachment to the PCL fibers. 
 
  
 25 
 
 
Figure 8: H&E and immunohistochemical staining of the cell-scaffold constructs after 14 days. H&E 
staining of A) the entire scaffold, and B) an expansion. Fibroblast nuclei were found through the 
entire thickness of the scaffold as indicated by the black arrows (B). The yellow arrows show PCL 
fibers within the stained section. Immunohistochemical staining for C) collagen type I, and D) 
fibronectin. Staining for collagen type I and fibronectin showed both ECM proteins were deposited by 
the fibroblasts throughout the thickness of the scaffold. 
